Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)
Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022
Abstract
To further improve the diagnosis and treatment of COVID-19, China National Health Commission and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID-19 Patients (Trial Version 8) and developed the Diagnosis and Treatment Protocol for COVID-19 Patients (Trial Version 9), summarizing the etiological characteristics, epidemiological characteristics, pathological changes, clinical features, diagnosis, clinical classification, population with high risk of severe/critical illnesses, early warning predictors for severe/critical illnesses, differential diagnosis, case identification and reporting, treatment, nursing, discharge criteria and precautions after discharge, patient transfer, control of nosocomial infection in medical institutions, and disease prevention.